Evidence map›Paper›PMID 36849093›Full record

ArticleActa tropica2023

Epidemiological situation of SARS-CoV-2 infection in Douala, the most populated and highly heterogeneous town of Cameroon: a post-vaccination update.

Arlette Flore Moguem Soubgui, Elisee Libert Embolo Enyegue, Loick Pradel Kojom Foko, Wilfried Steve Ndeme Mboussi, Gildas Deutou Hogoue, Suzy Pascale Mbougang, Sandra Michelle Sanda, Isaac Ulrich Fotso Chidjou, Valery Fabrice Fotso, Steve Armand Nzogang Tchonet and 2 more

Open access · greenAbstract read
In one paragraph

Article in Acta tropica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Arlette Flore Moguem SoubguiDepartment of Biochemistry, Faculty of Science, The University of Douala, Cameroon.
Elisee Libert Embolo EnyegueCenter for Research on Health and Priority Diseases, Ministry of Scientific Research and Innovation, Cameroon.
Loick Pradel Kojom FokoDepartment of Animal Organisms, Faculty of Science, The University of Douala, Cameroon.
Wilfried Steve Ndeme MboussiDepartment of Biochemistry, Faculty of Science, The University of Douala, Cameroon.
Gildas Deutou HogoueDepartment of Biochemistry, Faculty of Science, The University of Douala, Cameroon.
Suzy Pascale MbougangDepartment of Biochemistry, Faculty of Science, The University of Douala, Cameroon.
Sandra Michelle SandaDepartment of Biochemistry, Faculty of Science, The University of Douala, Cameroon.
Isaac Ulrich Fotso ChidjouDepartment of Biochemistry, Faculty of Science, The University of Douala, Cameroon.
Valery Fabrice FotsoDepartment of Biochemistry, Faculty of Science, The University of Douala, Cameroon.
Steve Armand Nzogang TchonetDepartment of Biochemistry, Faculty of Science, The University of Douala, Cameroon.
Christiane Medi SikeClinical Biology Laboratory, Douala Laquintinie Hospital, Cameroon.
Martin Luther Koanga MogtomoDepartment of Biochemistry, Faculty of Science, The University of Douala, Cameroon. Electronic address: koanga@yahoo.com.
University of Douala · CMMinistry of Scientific Research and Innovation · CM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed at providing an update of SARS-CoV-2 epidemiology in Douala, the most populated and highly heterogeneous town of Cameroon. A hospital-based cross sectional study was conducted from January to September 2022. A questionnaire was used to collect sociodemographic, anthropometric, and clinical data. Retrotranscriptase quantitative polymerase chain reaction was used to detect SARS-CoV-2 in nasopharyngeal samples. Of the 2354 individuals approached, 420 were included. The mean age of patients was 42.3 ± 14.4 years (range 21 - 82). The prevalence of SARS-CoV-2 infection was 8.1%. The risk of infection with SARS-CoV-2 was increased more than seven times in patients aged ≥ 70 years old (aRR = 7.12, p = 0.001), more than six times in married (aRR = 6.60, p = 0.02), more than seven times in those having completed secondary studies (aRR = 7.85, p = 0.02), HIV-positive patients (aRR = 7.64, p < 0.0001) and asthmatic patients (aRR = 7.60, p = 0.003), and more than nine times in those seeking health care regularly (aRR = 9.24, p = 0.001). In contrast, the risk of SARS-CoV-2 infection was reduced by 86% in patients attending Bonassama hospital (aRR = 0.14, p = 0.04), by 93% in patients of blood group B (aRR = 0.07, p = 0.04), and by 95% in COVID-19 vaccinated participants (aRR = 0.05, p = 0.005). There is need for ongoing surveillance of SARS-CoV-2 in Cameroon, given the position and importance of Douala.

Indexed as

COVID-19AdultAgedAged, 80 and overCameroonCross-Sectional StudiesHumansMiddle AgedSARS-CoV-2VaccinationYoung AdultCameroonDeterminantsPrevalenceSARS-CoV-2Update

Identifiers

PMID36849093
PMCPMC9968477
OpenAlexW4322124107

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.